These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15082596)

  • 81. Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease.
    Loo SY; Chan WK
    Hepatobiliary Surg Nutr; 2017 Apr; 6(2):135-137. PubMed ID: 28503563
    [No Abstract]   [Full Text] [Related]  

  • 82. Author Correction: Perceived stress and non-alcoholic fatty liver disease in apparently healthy men and women.
    Kang D; Zhao D; Ryu S; Guallar E; Cho J; Lazo M; Shin H; Chang Y; Sung E
    Sci Rep; 2020 Dec; 10(1):21978. PubMed ID: 33299030
    [No Abstract]   [Full Text] [Related]  

  • 83. Long-term outcomes in patients with non-alcoholic fatty liver disease: further evidence that a multidisciplinary and patient-centred approach to treatment is needed.
    Targher G
    Hepatobiliary Surg Nutr; 2022 Feb; 11(1):143-146. PubMed ID: 35284520
    [No Abstract]   [Full Text] [Related]  

  • 84. Correction: Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved.
    Eriksen PL; Thomsen KL; Hamilton-Dutoit S; Vilstrup H; Sørensen M
    BMC Gastroenterol; 2023 Feb; 23(1):49. PubMed ID: 36823549
    [No Abstract]   [Full Text] [Related]  

  • 85. Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention.
    Spivak I; Elinav E
    Hepatobiliary Surg Nutr; 2022 Jun; 11(3):492-494. PubMed ID: 35693394
    [No Abstract]   [Full Text] [Related]  

  • 86. Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease.
    Hidrus A; Hui Tung SE; Syed Abdul Rahim SS; Hayati F
    Oman Med J; 2022 Sep; 37(5):e425. PubMed ID: 36188884
    [No Abstract]   [Full Text] [Related]  

  • 87. Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease.
    Choi IY; Chang Y; Kang G; Jung HS; Shin H; Wild SH; Byrne CD; Ryu S
    Sci Rep; 2022 Dec; 12(1):21321. PubMed ID: 36494602
    [No Abstract]   [Full Text] [Related]  

  • 88. [A noteworthy disease: non-alcoholic fatty pancreatic disease].
    Liu PY; Liu XW; Jiang C
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(42):3283-3285. PubMed ID: 29141370
    [No Abstract]   [Full Text] [Related]  

  • 89. Noninvasive assessment of patients with alcoholic liver disease.
    Mueller S
    Clin Liver Dis (Hoboken); 2013 Apr; 2(2):68-71. PubMed ID: 30992827
    [No Abstract]   [Full Text] [Related]  

  • 90. IDENTIFICATION OF BLOOD CHARACTERISTICS COMMON TO ALCOHOLIC MALES.
    Williams RJ; Pelton RB; Hakkinen HM; Rogers LL
    Proc Natl Acad Sci U S A; 1958 Feb; 44(2):216-22. PubMed ID: 16590170
    [No Abstract]   [Full Text] [Related]  

  • 91. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
    Ekstedt M; Franzén LE; Mathiesen UL; Thorelius L; Holmqvist M; Bodemar G; Kechagias S
    Hepatology; 2006 Oct; 44(4):865-73. PubMed ID: 17006923
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
    Adams LA; Lymp JF; St Sauver J; Sanderson SO; Lindor KD; Feldstein A; Angulo P
    Gastroenterology; 2005 Jul; 129(1):113-21. PubMed ID: 16012941
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.
    White DL; Kanwal F; El-Serag HB
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1342-1359.e2. PubMed ID: 23041539
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ
    Hepatology; 2012 Jun; 55(6):2005-23. PubMed ID: 22488764
    [No Abstract]   [Full Text] [Related]  

  • 95. The natural history of nonalcoholic fatty liver: a follow-up study.
    Teli MR; James OF; Burt AD; Bennett MK; Day CP
    Hepatology; 1995 Dec; 22(6):1714-9. PubMed ID: 7489979
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
    Musso G; Gambino R; Cassader M; Pagano G
    Ann Med; 2011 Dec; 43(8):617-49. PubMed ID: 21039302
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A concise review of non-alcoholic fatty liver disease.
    Than NN; Newsome PN
    Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term follow-up of patients with nonalcoholic fatty liver.
    Rafiq N; Bai C; Fang Y; Srishord M; McCullough A; Gramlich T; Younossi ZM
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):234-8. PubMed ID: 19049831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.